// App-Quantinova.ai

T1198 2016 AHA : Enhancing Anti-thrombotic Efficacy but Reducing Hemorrhage: Comparison and Combination Use of a Novel Integrin Outside-in Signaling Inhibitor With Current Anti-platelet Drugs

Researchers

Presenter

  • Aiming Pang

Principal Investigators

  • Xiang Shen

  • Aleksandra Stojanovic

  • Xiaoping Du

Medical Centers

  • University of Illinios at Chicago, Chicago, IL

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • Hemostatic Solution

  • Ticagrelor

  • cangrelor

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved